BioNTech’s chief executive has said he is confident the Covid-19 vaccine his company pioneered with Pfizer will work against a new variant circulating in India, where health officials are recording hundreds of thousands of new coronavirus cases a day.
Ugur Sahin, who founded the German biotech with his wife Ozlem Tureci, said BioNTech had developed the vaccine with variants in mind.
“[It] will hold, I’m confident of that,” he said, adding that BioNTech’s early experience developing cancer therapies meant that the company had been prepared for the virus to mutate.
您已閱讀13%（567字），剩余87%（3717字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。